The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Direct interaction of Cbl with pTyr 1045 of the EGF receptor (EGFR) is required to sort the EGFR to lysosomes for degradation
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cell Signaling by Receptor Tyrosine Kinases
Schlessinger, J. (2000) · Cell · doi:10.1016/s0092-8674(00)00114-8 · Cited by 3,774
Cited by
Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
Imielinski, M., Berger, A. H., Hammerman, P. S., Hernandez, B., Pugh, T. J., Hodis, E., Cho, J., Suh, J., Capelletti, M., Sivachenko, A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.029 · Cited by 1,789
“The CGC-only PPH2 and LOF analyses yielded 15 and 10 genes, respectively, including CTNNB1, FGFR3, ATM, CBL, PIK3CA, PTEN, FBXW7, ARID1A, and SETD2 (Tables S3C and S3D).”
BackgroundTargeting the EGFR signaling pathway in cancer therapy
Seshacharyulu, P., Ponnusamy, M. P., Haridas, D., Jain, M., Ganti, A. K., & Batra, S. K. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.648617 · Cited by 913
Stem Cell Factor Receptor/c-Kit: From Basic Science to Clinical Implications
Lennartsson, J., & Rönnstrand, L. (2012) · Physiological Reviews · doi:10.1152/physrev.00046.2011 · Cited by 825
Understanding resistance to EGFR inhibitors—impact on future treatment strategies
Wheeler, D. L., Dunn, E. F., & Harari, P. M. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.97 · Cited by 683
Global, quantitative and dynamic mapping of protein subcellular localization
Itzhak, D. N., Tyanova, S., Cox, J., & Borner, G. H. (2016) · eLife · doi:10.7554/elife.16950 · Cited by 649
Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members
Wheeler, D. L., Huang, S., Kruser, T. J., Nechrebecki, M. M., Armstrong, E. A., Benavente, S., Gondi, V, Hsu, K.-T., & Harari, P. M. (2008) · Oncogene · doi:10.1038/onc.2008.19 · Cited by 550
Zhang, Y., Wolf-Yadlin, A., Ross, P. L., Pappin, D. J., Rush, J., Lauffenburger, D. A., & White, F. M. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500089-mcp200 · Cited by 541
Somatic Mutations Lead to an Oncogenic Deletion of Met in Lung Cancer
Kong-Beltran, M., Seshagiri, S., Zha, J., Zhu, W., Bhawe, K., Mendoza, N., Holcomb, T., Pujara, K., Stinson, J., Fu, L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2749 · Cited by 490
Carey, K. D., Garton, A. J., Romero, M. S., Kahler, J., Thomson, S., Ross, S., Park, F., Haley, J. D., Gibson, N., & Sliwkowski, M. X. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0453 · Cited by 445
“Reduction of Y1045 phosphorylation would reduce Cbl association, resulting in decreased EGFR cell surface down-regulation through receptor ubiquitinylation, thereby prolonging receptor activation and enhancing downstream signaling (41, 42).”
BackgroundThe Molecular Mechanism of Hepcidin-mediated Ferroportin Down-Regulation
De Domenico, I., Ward, D. M., Langelier, C., Vaughn, M. B., Nemeth, E., Sundquist, W. I., Ganz, T., Musci, G., & Kaplan, J. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-01-0060 · Cited by 434
The Cbl interactome and its functions
Schmidt, M. H. H., & Dikic, I. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1762 · Cited by 395
The role of ubiquitylation in receptor endocytosis and endosomal sorting
Haglund, K., & Dikic, I. (2012) · Journal of Cell Science · doi:10.1242/jcs.091280 · Cited by 313
Differential effects of EGFR ligands on endocytic sorting of the receptor
Roepstorff, K., Grandal, M. V., Henriksen, L., Knudsen, S. L. J., Lerdrup, M., Grøvdal, L., Willumsen, B. M., & Van Deurs, B. (2009) · Traffic · doi:10.1111/j.1600-0854.2009.00943.x · Cited by 310
Self-citationIntegration of EGFR inhibitors with radiochemotherapy
Nyati, M. K., Morgan, M. A., Feng, F. Y., & Lawrence, T. S. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1953 · Cited by 304
The Cbl family proteins: Ring leaders in regulation of cell signaling
Swaminathan, G., & Tsygankov, A. Y. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20694 · Cited by 291
Molecular mechanisms of resistance to the EGFR monoclonal antibody cetuximab
Brand, T. M., Iida, M., & Wheeler, D. L. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.11.9.15050 · Cited by 273
Martinelli, S., De Luca, A., Stellacci, E., Rossi, C., Checquolo, S., Lepri, F., Caputo, V., Silvano, M., Buscherini, F., Consoli, F., et al. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.06.015 · Cited by 259
Chung, B. M., Raja, S. M., Clubb, R. J., Tu, C., George, M., Band, V., & Band, H. (2009) · BMC Cell Biology · doi:10.1186/1471-2121-10-84 · Cited by 89
Koustas, E., Karamouzis, M. V., Mihailidou, C., Schizas, D., & Papavassiliou, A. G. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.03.023 · Cited by 79
A Tale of Two Cbls: Interplay of c-Cbl and Cbl-b in Epidermal Growth Factor Receptor Downregulation
Pennock, S., & Wang, Z. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01809-07 · Cited by 83
Casey, F. P., Baird, D., Feng, Q., Gutenkunst, R. N., Waterfall, J. J., Myers, C. R., Brown, K. S., Cerione, R. A., & Sethna, J. P. (2007) · IET Systems Biology · doi:10.1049/iet-syb:20060065 · Cited by 77
Amessou, M., Ebrahim, A. S., Dilly, A., Joseph, M., Tabolina, M., Chukkapalli, S., Meroueh, L., Syed, J. T., Liddane, A., Lang, S. L., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13008 · Cited by 5
Metadata
- Authors
- Grøvdal, L. M., Stang, E., Sorkin, A., & Madshus, I. H.
- Venue
- Experimental Cell Research
- Publisher
- Elsevier BV
- Published
- 2004-11
- Volume
- 300
- Issue
- 2
- Pages
- 388-395
- ISSN
- 0014-4827 (ISSN-L)
- OpenAlex
- W1965549967
- Cited by
- 182
- References
- 1
- FWCI
- 4.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.